Evan Lippman

Corporate Officer/Principal at ALNYLAM PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profile

Evan Lippman is currently the Chief Corporate Development & Strategy Officer at Alnylam Pharmaceuticals, Inc. Prior to his current position, he held the role of Senior VP, Chief Financial & Business Officer at Aileron Therapeutics, Inc. from 2015 to 2016.
He also served as the Senior Vice President-Neurodegenerative Diseases at EMD Serono, Inc. and as the President & Chief Operating Officer at Intima Bioscience, Inc. Mr. Lippman completed his undergraduate studies at Bucknell University and Georgia State University.
He holds an MBA from Cornell University.

Evan Lippman active positions

Companies	Position	Start
ALNYLAM PHARMACEUTICALS, INC.	Corporate Officer/Principal	2022-09-20

All active positions of Evan Lippman

Former positions of Evan Lippman

Companies	Position	End
AILERON THERAPEUTICS, INC.	Director of Finance/CFO	2016-12-30
Intima Bioscience, Inc. Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021.	President	-
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Corporate Officer/Principal	-

See the detail of Evan Lippman's experience

Training of Evan Lippman

Bucknell University	Undergraduate Degree
Georgia State University	Undergraduate Degree
Cornell University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Evan Lippman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
AILERON THERAPEUTICS, INC.	Health Technology
ALNYLAM PHARMACEUTICALS, INC.	Health Technology

Private companies	2
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Health Technology
Intima Bioscience, Inc. Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021.	Health Technology